rs144606152

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001123385.2(BCOR):​c.1791C>T​(p.His597His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0436 in 1,211,156 control chromosomes in the GnomAD database, including 977 homozygotes. There are 16,949 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 58 hom., 1026 hem., cov: 25)
Exomes 𝑓: 0.045 ( 919 hom. 15923 hem. )

Consequence

BCOR
NM_001123385.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0260

Publications

5 publications found
Variant links:
Genes affected
BCOR (HGNC:20893): (BCL6 corepressor) The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
BCOR Gene-Disease associations (from GenCC):
  • microphthalmia, syndromic 2
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, ClinGen, Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • microphthalmia, Lenz type
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-40073555-G-A is Benign according to our data. Variant chrX-40073555-G-A is described in ClinVar as [Benign]. Clinvar id is 95767.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.026 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0545 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCORNM_001123385.2 linkc.1791C>T p.His597His synonymous_variant Exon 4 of 15 ENST00000378444.9 NP_001116857.1 Q6W2J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCORENST00000378444.9 linkc.1791C>T p.His597His synonymous_variant Exon 4 of 15 1 NM_001123385.2 ENSP00000367705.4 Q6W2J9-1

Frequencies

GnomAD3 genomes
AF:
0.0318
AC:
3598
AN:
113134
Hom.:
58
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.00686
Gnomad AMI
AF:
0.0131
Gnomad AMR
AF:
0.0221
Gnomad ASJ
AF:
0.0621
Gnomad EAS
AF:
0.000278
Gnomad SAS
AF:
0.0122
Gnomad FIN
AF:
0.0340
Gnomad MID
AF:
0.0625
Gnomad NFE
AF:
0.0497
Gnomad OTH
AF:
0.0379
GnomAD2 exomes
AF:
0.0345
AC:
6314
AN:
183017
AF XY:
0.0349
show subpopulations
Gnomad AFR exome
AF:
0.00623
Gnomad AMR exome
AF:
0.0188
Gnomad ASJ exome
AF:
0.0623
Gnomad EAS exome
AF:
0.0000721
Gnomad FIN exome
AF:
0.0372
Gnomad NFE exome
AF:
0.0517
Gnomad OTH exome
AF:
0.0431
GnomAD4 exome
AF:
0.0448
AC:
49170
AN:
1097967
Hom.:
919
Cov.:
31
AF XY:
0.0438
AC XY:
15923
AN XY:
363357
show subpopulations
African (AFR)
AF:
0.00633
AC:
167
AN:
26402
American (AMR)
AF:
0.0187
AC:
660
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.0607
AC:
1176
AN:
19386
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.0140
AC:
760
AN:
54148
European-Finnish (FIN)
AF:
0.0387
AC:
1559
AN:
40262
Middle Eastern (MID)
AF:
0.0607
AC:
251
AN:
4135
European-Non Finnish (NFE)
AF:
0.0506
AC:
42622
AN:
842124
Other (OTH)
AF:
0.0428
AC:
1973
AN:
46097
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2294
4587
6881
9174
11468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1604
3208
4812
6416
8020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0318
AC:
3594
AN:
113189
Hom.:
58
Cov.:
25
AF XY:
0.0290
AC XY:
1026
AN XY:
35335
show subpopulations
African (AFR)
AF:
0.00685
AC:
214
AN:
31263
American (AMR)
AF:
0.0221
AC:
239
AN:
10833
Ashkenazi Jewish (ASJ)
AF:
0.0621
AC:
165
AN:
2655
East Asian (EAS)
AF:
0.000279
AC:
1
AN:
3582
South Asian (SAS)
AF:
0.0122
AC:
34
AN:
2779
European-Finnish (FIN)
AF:
0.0340
AC:
214
AN:
6297
Middle Eastern (MID)
AF:
0.0639
AC:
14
AN:
219
European-Non Finnish (NFE)
AF:
0.0496
AC:
2647
AN:
53328
Other (OTH)
AF:
0.0368
AC:
57
AN:
1548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
132
264
396
528
660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0454
Hom.:
373
Bravo
AF:
0.0294
EpiCase
AF:
0.0545
EpiControl
AF:
0.0560

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 13, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

History of neurodevelopmental disorder Benign:1
Jan 09, 2013
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance -

Oculofaciocardiodental syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.48
DANN
Benign
0.48
PhyloP100
-0.026
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144606152; hg19: chrX-39932808; COSMIC: COSV60705224; COSMIC: COSV60705224; API